Impact of the intragastric location of extended release tablets on food interactions.

Gastrointestinal motility and transport as well as concomitant food intake are factors that are known to influence pharmacokinetics derived after intake of extended release dosage forms. However, the mechanisms behind these influencing factors are mostly unknown. In this study the gastrointestinal transit and the in vivo drug release of magnetically labelled extended release tablets containing felodipine were monitored together with the drug absorption phase of pharmacokinetics under fasting and fed conditions in six healthy volunteers using Magnetic Marker Monitoring. It was found that the in vivo drug release profiles of the tablets compared well under fasting and fed conditions. However, the plasma concentration profiles were strongly influenced by concomitant food intake. This could be attributed to elongated residence of the tablets in proximal parts of the stomach, resulting in delayed drug absorption and the occurrence of late high plasma peak concentrations. The lag time until the first appearance of felodipine in plasma and the residence time of the tablets in the proximal stomach, were found to be directly correlated. The study shows that increased plasma peak drug concentrations after intake of extended release formulations together with food can be explained by poor mixing in the proximal part of the stomach and are not necessarily due to failure of the formulation to control drug release (dose dumping).

[1]  M. Alpsten,et al.  Absorption, Gastrointestinal Transit, and Tablet Erosion of Felodipine Extended-Release (ER) Tablets , 1993, Pharmaceutical Research.

[2]  M. Castedal Scintigraphic Assessment of Interdigestive Duodenogastric Reflux in Humans: Distinguishing between Duodenal and Biliary Reflux Material , 2000, Scandinavian journal of gastroenterology.

[3]  W Weitschies,et al.  Determination of the disintegration behavior of magnetically marked tablets. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  F. Langenbucher in vitroとin vivoの薬物利用率を関連づける手段としての数字であらわしたコンボルューションとデコンボルューション , 1982 .

[5]  G. Shorten,et al.  Delayed postoperative gastric emptying following intrathecal morphine and intrathecal bupivacaine , 1999, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[6]  Lutz Trahms,et al.  Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. , 2005, Advanced drug delivery reviews.

[7]  E. Brendel,et al.  Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast , 2002, European Journal of Clinical Pharmacology.

[8]  N. Shibata,et al.  Application of a Biomagnetic Measurement System (BMS) to the Evaluation of Gastrointestinal Transit of Intestinal Pressure-Controlled Colon Delivery Capsules (PCDCs) in Human Subjects , 2000, Pharmaceutical Research.

[9]  R. Schall,et al.  The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast. , 2002, British journal of clinical pharmacology.

[10]  James G Brasseur,et al.  Gastric flow and mixing studied using computer simulation , 2004, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[11]  G. Dresser,et al.  Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice , 2003, Clinical pharmacology and therapeutics.

[12]  L Trahms,et al.  Magnetic marker monitoring of disintegrating capsules. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  J. Sjögren,et al.  Investigation of prandial effects on hydrophilic matrix tablets. , 1999, Drug development and industrial pharmacy.

[14]  E. Brendel,et al.  Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  H. Bergmann,et al.  Effects of oral cyclotropium bromide, hyoscine N-butylbromide and placebo on gastric emptying and antral motor activity in healthy man. , 1984, Gut.

[16]  L. Houghton,et al.  Physiology of gastric emptying and pathophysiology of gastroparesis. , 1989, Gastroenterology clinics of North America.

[17]  A. Schneider,et al.  The effect of ethanol and alcoholic beverages on gastric emptying of solid meals in humans. , 2005, Alcohol and alcoholism.

[18]  Jooil Kim,et al.  Food-Effect Bioavailability and Fed Bioequivalence Studies , 2005 .

[19]  D. Drung The PTB 83-SQUID system for biomagnetic applications in a clinic , 1995, IEEE Transactions on Applied Superconductivity.

[20]  M. Ahnoff,et al.  Comparison of high-selectivity gas chromatographic methods, including column switching, for the determination of felodipine in plasma. , 1987, Journal of chromatography.

[21]  C. Regårdh,et al.  Felodipine kinetics in healthy men , 1985, Clinical pharmacology and therapeutics.

[22]  M. Alpsten,et al.  Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. , 1998, Journal of controlled release : official journal of the Controlled Release Society.